First clinical images from Sectra's MicroDose Mammography system show very promising results

First clinical images from Sectra's MicroDose Mammography system show very promising results The Swedish IT and medical technology company Sectra announces that its MicroDose Mammography system is now clinically operational at St: Göran Hospital in Stockholm, Sweden. "The initial results from our tests of the Sectra MicroDose MammographyTM system look very promising. The tests indicate that the images will reach the quality and dose levels we have seen in laboratory studies", says Karin Leifland, MD, director of the mammography department at St Göran's. Sectra MicroDose MammographyTM is a digital mammography system based on a completely new digital technology which, at the same image quality as the current film-based systems, gives a five-fold reduction in absorbed radiation dose to examined women. Sectra is planning to deliver the first units to Scandinavian mammography departments in 2002. Deliveries in the USA depend on FDA approval and is planned to start in 2003. Clinical trials of Sectra MicroDose MammographyTM in the USA will be performed in co-operation with Professor Etta Pisano and the University of North Carolina School of Medicine, Chapel Hill, North Carolina. The goal is to begin these clinical trials in the second half of next year. Sectra is one of today's major PACS providers with more than 200 PACS installations worldwide. The Swedish based company operates through partners in most of the world, but delivers directly to end customers in Northern Europe. The core business is to deliver top-of-the-line high- availability, robust enterprise PACS for 24/7 operation. In Sweden, which is currently the country with the largest penetration of PACS in the world, Sectra holds a dominant market leadership with more than 60% of all film free installations. The company has its largest number of installed systems in Sweden and the US (through partners), but has also an installed base in Germany, Norway, Finland, UK, Italy, Spain, The Netherlands and the Far East. [REMOVED For further information, please contact: GRAPHICS] Sectra Imtec AB, Dr Torbjörn Kronander, President, +46 705 23 52 27, or Sectra AB, Dr Jan-Olof Brüer, President and CEO, +46 705 23 52 09, Visit our website Sectra's operations Sectra has its roots in Linköping Technical University and is one of Sweden's fastest growing high-tech companies in the IT area. Since the mid-1980s, Sectra has successfully conducted development and sales of high-technology medical IT and telecommunications products. Today, the business includes products in medical systems, secure communication systems and wireless information systems. Sectra's medical business is conducted in Sectra Imtec AB, which is a wholly-owned subsidiary of Sectra AB. Internationally, Sectra PACS is marketed and sold through different partners. The new mammography detector is developed and produced by Mamea Imaging AB, Stockholm, Sweden, a company that is co-owned by Sectra-Imtec AB and the inventors. All sales of Mamea Imaging AB are exclusively done through Sectra. Business is conducted in six countries with a total of 195 employees. Sales for the fiscal year May 2000-April 2001 reached SEK 292 million. Since March 1999, Sectra's shares have been quoted on the O list of the OM Stockholm Exchange. ------------------------------------------------------------ This information was brought to you by Waymaker The following files are available for download:

About Us

Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. Thereby, Sectra contributes to a healthier and safer society. The company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2018/2019 fiscal year totaled SEK 1,413 million. The Sectra share (STO: SECT B) is quoted on the Nasdaq Stockholm exchange. For more information, visit